Literature DB >> 9723236

The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.

K R Schultz1, T J Nevill, C L Toze, T Corr, C Currie, D K Strong, P A Keown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9723236     DOI： 10.1016/s0041-1345(98)00385-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

Authors:  Abraham J Wilhelm; Peer de Graaf; Agnes I Veldkamp; Jeroen J W M Janssen; Peter C Huijgens; Eleonora L Swart
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 2.  Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

Authors:  María del Mar Fernández De Gatta; Dolores Santos-Buelga; Alfonso Domínguez-Gil; María José García
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.

Authors:  Hanene Eljebari; Emna Gaies; Nadia Ben Fradj; Nadia Jebabli; Issam Salouage; Sameh Trabelsi; Mohamed Lakhal; Anis Klouz
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

Review 4.  Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.

Authors:  C J Dunn; A J Wagstaff; C M Perry; G L Plosker; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Ciclosporin kinetics in children after stem cell transplantation.

Authors:  A J Willemze; S C Cremers; R C Schoemaker; A C Lankester; J den Hartigh; J Burggraaf; J M Vossen
Journal:  Br J Clin Pharmacol       Date:  2008-04-30       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.